6月2日，科济药业-B盘中下跌5.14%，报16.41港元/股，成交额3187.27万港元。
消息面上，公司此前完成先旧后新配售2370万股，配售价每股19.84港元，净筹约4.62亿港元，配售完成后已发行股本增至约5.95亿股。折价配股带来的稀释效应叠加机构持续减持，短期对市场情绪形成压制。资金用途方面，70%将用于创新药全球临床开发，15%用于研发与生产设备设施，15%用于营运资金。此外，港股生物科技板块整体走弱，三生制药跌7.4%、科伦博泰生物跌3.95%、康方生物跌3.02%、百济神州跌2.22%、信达生物跌2.1%，行业估值承压进一步加剧个股调整。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.